Search Results 211-220 of 799 for 贵阳软件开发公司 www.w-t.cn
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this study is to prospectively define the incidence of new and/or worsening hypertension in patients with B-cell malignancies on Bruton Tyrosine ...
About this study. This randomized phase II trial studies how well pazopanib hydrochloride works in treating patients with carcinoid tumors that are growing, ...
The purpose of this study is to test a digital health tool developed collaboratively by Mayo Clinic inverstigators and a digital health company to improve the ...
About this study. The purpose of this study is to estimate the real-world Objective Response Rate (rwORR) to standard therapy in subjects with locally ...
About this study. This procedure allows patients to use the Humanitarian Use Device, IBV® Valve System. Participation eligibility.
Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving ixabepilone together with temsirolimus may kill ...
D., is focused on investigating disease mechanisms associated with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS), two fatal diseases ...
About this study. The purpose of this study is to to explain the mechanisms of brain resilience and susceptibility to post-stroke cognitive impairment and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.